Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m).
Marshall A, Levine M, Hill C, Hale D, Thirlwall J, Wilkie V, French K, Kakkar A, Lokare A, Maraveyas A, Chapman O, Arif A, Petrou S, Maredza M, Hobbs R, Dunn JA, Young AM.
Marshall A, et al. Among authors: arif a.
J Thromb Haemost. 2020 Apr;18(4):905-915. doi: 10.1111/jth.14752. Epub 2020 Feb 26.
J Thromb Haemost. 2020.
PMID: 31995662
Free article.
Clinical Trial.